SURG.NASDAQSurgepays, INC

Form 4: SurgePays CEO Sells Shares to Cover Taxes After Vesting

Sentiment:

SEC Form 4 Filing


SurgePays CEO Kevin Brian Cox sold 35,180 shares of common stock to cover taxes associated with the vesting of restricted share awards.

Summary

  • SurgePays CEO and Chairman of the Board, Kevin Brian Cox, sold 35,180 shares of common stock on December 3, 2024.
  • The sale was executed to cover tax obligations arising from the vesting of restricted share awards.
  • The shares were sold at an average price of $1.8216, with prices ranging from a high of $1.88 to a low of $1.77.
  • Following the transaction, Cox still beneficially owns 5,770,090 shares of SurgePays common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is not indicative of any negative sentiment towards the company, but it is not a positive catalyst either.

Management Comments

  • The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock vests.

Comparison to Industry Standards

  • Executive stock sales to cover taxes are a common practice across publicly traded companies.
  • The sale of 35,180 shares is relatively small compared to the total holdings of 5,770,090 shares, suggesting it is a routine tax-related transaction rather than a significant divestment.
  • Similar transactions are regularly reported by executives at other companies, such as those in the technology and telecommunications sectors, where stock-based compensation is prevalent.

Stakeholder Impact

  • The sale has a minimal impact on shareholders as it is a small percentage of the CEO's total holdings.
  • The transaction is not expected to affect employees, customers, or suppliers.

Key Dates

DateDescription
12/03/2024Date of the stock sale transaction.
12/04/2024Date the Form 4 was signed.

Keywords

SurgePays, stock sale, insider trading, Form 4, Kevin Brian Cox, executive compensation, share vesting, tax obligations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.